Dow Futures Turn Positive As Syria Vote Approaches

Stock index futures indicate a strong start for the Dow Jones and S&P 500 today, as Congress returns from recess and prepares for a vote on military action in Syria.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

LONDON — Stock index futures at 7am ET indicate that the Dow Jones Industrial Average (DJINDICES: ^DJI) may open up by 0.24% this morning, while the S&P 500 (SNPINDEX: ^GSPC) may open 0.28% higher. The CNN Fear & Greed Index remains in ‘fear’ territory, and is set to open at 36 today, after closing at 33 on Friday.

Despite strong gains overnight for Asian markets, European markets edged lower this morning, as uncertainty over western intervention in Syria continues. In China, exports rose by 7.2% in August compared to the same period last year, beating consensus forecasts for 5.5% growth, but this positive data failed to lift sentiment as the ongoing prospect of Fed tapering also weighed on European markets. In corporate news, pharmaceutical firm GlaxoSmithKline announced that it has agreed to sell its Ribena and Lucozade drinks to Japan’s Suntory, for £1.35bn (about $2.1bn). At 7am ET, the FTSE 100 was down 0.4% and the DAX was unchanged.

In the US today, economic reports are limited to July’s consumer credit figures at 3pm ET, and investors are likely to focus far more closely on President Obama’s chances of success this week as he tries to persuade Congress to vote to authorise US air strikes against Syria. The likelihood of the Federal Open Markets Committee deciding to start tapering the Fed’s bond-buying programme when it meets next week is also likely to remain a key issue for investors.

Companies scheduled to report quarterly earnings before markets open today include Hovnanian Enterprises, while Palo Alto Networks, Five Below, Casey’s General Stores and Pep Boys are expected to report after the closing bell today.

In other corporate news, Apple stock may be actively traded today after the company issued invitations to a presentation on Tuesday that it says should “brighten everyone’s day”. Apple is widely expected to unveil its latest iPhone models at the presentation, and may also announce details of a partnership with China Mobile, which has 700 million subscribers, and could be a major new sales channel for the iPhone. Apple stock was up 1.2% in pre-market trading this morning and has gained 25% since the start of July. Smithfield Foods may also gain on Friday’s post-close news that US regulators have approved the firm’s acquisition by China’s Shuanghui International.

Finally, let’s not forget the Dow’s daily movements can add up to some serious long-term gains. Indeed, Warren Buffett recently wrote: “The Dow advanced from 66 to 11,497 in the 20th Century, a staggering 17,320% increase that materialized despite four costly wars, a Great Depression and many recessions.” If you, like Buffett, are convinced about the long-term power of the Dow, you should read “5 Stocks To Retire On“. Your long-term wealth could be transformed, even in this uncertain economy. Simply click here now to download this free, no-obligation report.

> Roland owns shares in GlaxoSmithKline but does not own shares in any of the other companies mentioned in this article. The Motley Fool has recommended shares in GlaxoSmithKline.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

Investing Articles

With a 6% dividend, is this company a passive income no-brainer?

Dividend paying companies can be a game changer for building a passive income, but is this company the answer? Gordon…

Read more »

Investing Articles

2 value shares I’d happily snap up in a heartbeat

These two value shares look great value for money, and both possess their own unique offering with bullish traits our…

Read more »

Investing Articles

Up 13% in 2024, is the Aviva share price just getting started?

The Aviva share price has had a great 2024 to date, but is there more to come from this insurance…

Read more »

Growth Shares

This FTSE 250 stock fell 15% yesterday. Here’s why I want to buy the dip

Jon Smith talks through the negative news that caused a FTSE 250 stock to fall yesterday but flags up why…

Read more »

Investing Articles

1 under the radar stock I’d buy for my Stocks and Shares ISA

This Fool is looking for good dividend stocks to buy for her Stocks and Shares ISA and earmarks this investment…

Read more »

Investing Articles

This company might even beat the Amazon share price over the next few years

The Amazon share price is pretty synonymous with e-commerce investments, but I think there's a more appealing company out there.

Read more »

Investing Articles

1 growth stock that could skyrocket over the next 10 years

This investor is excited about the transformational potential of one growth stock that he's been eyeing up for his portfolio.

Read more »

Investing Articles

This penny stock once looked destined for big things! What’s happened?

Sumayya Mansoor had high hopes for this penny stock in the past but the wheels look to have come off…

Read more »